Autolus Therapeutics - ADR Peer Comparison

$2.33

$-0.11 (-4.51%)

As on 26-Aug-2026 16:00EDT

Market cap

$641 Mln

Revenue (TTM)

$117 Mln

P/E Ratio

--

P/B Ratio

8.6

Div. Yield

0 %

Edit

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	641	16,614	17,326	13,400	12,305
Revenue ($ Mln)	117	1,054	2,782	2,436	670
Net Profit ($ Mln)	-280.03	755.85	491.50	860.62	-319.95
Net Margin (%)	-238.62	71.69	17.67	35.33	-47.79
RoE (%)	-221.39	--	110.09	42.98	-71.14
Price to Earnings	--	19.38	36.49	17.01	--
Price-To-Book	8.55	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	117.35	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	98.97	103.47	1,982.07	85.67	19.14
Gross Profit	-21.03	588.53	760.62	2,236.43	829.45
Operating Expenses	265.72	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	-247.33	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-279.35	101.11	598.92	1,035.47	-252.08
Provision for Tax	0.68	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	-280.03	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	74.84	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	349.60	384.48	187.89	288.55	1,362.63
Current Liabilities	68.79	464.70	1,435.43	361.93	283.35
Total Liabilities	589.07	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	157.14	895.24	1,006.90	1,243.41	440.60
Current Assets	336.09	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	589.07	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	83.51	449.89	120.10	165.93	864.07
Net Current Assets	0.00	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-283.57	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	158.46	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	-4.34	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-57.09	-30.01	53.56	32.82	-0.17
ROE (%)	-221.39	163.18	110.09	42.98	-71.14
ROA (%)	-34.60	26.53	15.64	29.32	-16.12
EBIT Margin (%)	-197.90	5.73	21.13	31.04	-0.77
Net Margin (%)	-238.62	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	292.05	114.85	24.67	9.23	12.22
EBIT Growth (%)	6.66	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	-22.94	378.76	17.50	42.89	-115.58
EPS Growth (%)	-22.93	353.27	26.84	50.42	-73.87
Book Value Growth (%)	-78.40	816.12	164.02	-0.70	-13.57

Valuation Ratios

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-1.84	-59.76	36.06	15.79	-2,869.63
Price / Book Value	2.97	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-2.32	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.08	0.05	0.00	0.00	0.09
Current Ratio	4.89	2.99	0.73	3.46	5.90
Quick Ratio	4.40	2.32	0.73	3.38	5.90
Interest Coverage	-4.93	1.62	--	--	-1.72

Operating Efficiency Ratios

	Autolus Therapeutics - ADR	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	37.83	21.25	15.88	13.74	1.28
Asset Turnover	0.15	0.37	0.89	0.83	0.34
Receivable days	299.76	85.52	50.42	43.48	1.50
Inventory Days	70.61	1,056.70	--	96.17	--
Payable days	9.55	331.01	6.26	147.97	221.81
Cash Conversion Cycle	360.81	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly